Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 0 results

Early research (Phase 1)Study completedNCT03596294
What this trial is testing

A Study in Healthy Male Subjects to Investigate Whether Administration of Rifampicin Can Affect the Fate of Clazosentan in the Body of Clazosentan

Who this might be right for
Healthy Subjects
Idorsia Pharmaceuticals Ltd. 14
Not applicableEnded earlyNCT04093622
What this trial is testing

Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy

Who this might be right for
Hematological Malignancy
Fate Therapeutics 2
Early research (Phase 1)Study completedNCT03372629
What this trial is testing

Evaluate if ID-085 is Safe, Its Fate in the Body as Well as Its Potential Effects on the Body in Healthy Subjects

Who this might be right for
Healthy Subjects
Idorsia Pharmaceuticals Ltd. 88
Early research (Phase 1)Study completedNCT03593278
What this trial is testing

Evaluate ACT-246475 Fate in Healthy Male Subjects

Who this might be right for
Healthy Subjects
Viatris Innovation GmbH 6
Early research (Phase 1)Study completedNCT04555811
What this trial is testing

FT596 With Rituximab as Relapse Prevention After Autologous HSCT for NHL

Who this might be right for
NHLNon Hodgkin LymphomaDiffuse Large B Cell Lymphoma+1 more
Masonic Cancer Center, University of Minnesota 7
Testing effectiveness (Phase 2)Looking for participantsNCT07570862
What this trial is testing

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

Who this might be right for
Lupus NephritisSystemic Lupus ErythematosusSLE - Systemic Lupus Erythematosus+2 more
Fate Therapeutics 53
Not applicableStudy completedNCT02562105
What this trial is testing

Prognosis of Hematological Cancer Patient Underwent Mechanical Ventillation

Who this might be right for
Hematological MalignancyAcute Respiratory FailureMechanical Ventilation
Mansoura University 50
Early research (Phase 1)Study completedNCT03081780
What this trial is testing

Open Label NK Cell Infusion (FATE-NK100) With Subq IL-2 in Adults With AML

Who this might be right for
Refractory Acute Myelogenous LeukemiaRelapsed Acute Myelogenous Leukemia
Masonic Cancer Center, University of Minnesota 6
Not applicableUnknownNCT04584073
What this trial is testing

Secretory Otitis Media in Adenoids Hypertrophy Patients

Who this might be right for
Otitis Media With Effusion
Assiut University 150
Not applicableLooking for participantsNCT07152431
What this trial is testing

Fibrosis Associated Protein Inhibitor (FAPI) Radiotracer-based Imaging to Identify Fibrotic Intestinal Crohn's Disease

Who this might be right for
Crohn Disease
University of Edinburgh 30
Early research (Phase 1)Study completedNCT03173625
What this trial is testing

A Study Conducted in Healthy Male Subjects to Investigate the Safety and Tolerability of AC-76, Its Fate in the Body, and Its Effect on the Body

Who this might be right for
Healthy Subjects
Viatris Innovation GmbH 72